Steimle V - Search Results

1

PML promotes MHC class II gene expression by stabilizing the class II transactivator.

Ulbricht T, Alzrigat M, Horch A, Reuter N, von Mikecz A, Steimle V, Schmitt E, Krämer OH, Stamminger T, Hemmerich P. Ulbricht T, et al. Among authors: steimle v. J Cell Biol. 2012 Oct 1;199(1):49-63. doi: 10.1083/jcb.201112015. Epub 2012 Sep 24. J Cell Biol. 2012. PMID: 23007646 Free PMC article.

2

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

Steimle V, Otten LA, Zufferey M, Mach B. Steimle V, et al. Cell. 1993 Oct 8;75(1):135-46. Cell. 1993. PMID: 8402893

3

CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.

Hake SB, Masternak K, Kammerbauer C, Janzen C, Reith W, Steimle V. Hake SB, et al. Among authors: steimle v. Mol Cell Biol. 2000 Oct;20(20):7716-25. doi: 10.1128/MCB.20.20.7716-7725.2000. Mol Cell Biol. 2000. PMID: 11003667 Free PMC article.

4

NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.

Neerincx A, Rodriguez GM, Steimle V, Kufer TA. Neerincx A, et al. Among authors: steimle v. J Immunol. 2012 May 15;188(10):4940-50. doi: 10.4049/jimmunol.1103136. Epub 2012 Apr 6. J Immunol. 2012. PMID: 22490867

5

The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.

Neerincx A, Jakobshagen K, Utermöhlen O, Büning H, Steimle V, Kufer TA. Neerincx A, et al. Among authors: steimle v. J Immunol. 2014 Sep 15;193(6):3090-100. doi: 10.4049/jimmunol.1401065. Epub 2014 Aug 15. J Immunol. 2014. PMID: 25127861

6

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Steimle V, et al. Science. 1994 Jul 1;265(5168):106-9. doi: 10.1126/science.8016643. Science. 1994. PMID: 8016643

7

Quantitative control of MHC class II expression by the transactivator CIITA.

Otten LA, Steimle V, Bontron S, Mach B. Otten LA, et al. Among authors: steimle v. Eur J Immunol. 1998 Feb;28(2):473-8. doi: 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E. Eur J Immunol. 1998. PMID: 9521055 Free article.

8

Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes.

Otten LA, Tacchini-Cottier F, Lohoff M, Annunziato F, Cosmi L, Scarpellino L, Louis J, Steimle V, Reith W, Acha-Orbea H. Otten LA, et al. Among authors: steimle v. J Immunol. 2003 Feb 1;170(3):1150-7. doi: 10.4049/jimmunol.170.3.1150. J Immunol. 2003. PMID: 12538670

9

N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.

Schnappauf F, Hake SB, Camacho Carvajal MM, Bontron S, Lisowska-Grospierre B, Steimle V. Schnappauf F, et al. Among authors: steimle v. Eur J Immunol. 2003 Aug;33(8):2337-47. doi: 10.1002/eji.200323490. Eur J Immunol. 2003. PMID: 12884309 Free article.

10

Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport.

Camacho-Carvajal MM, Klingler S, Schnappauf F, Hake SB, Steimle V. Camacho-Carvajal MM, et al. Among authors: steimle v. Int Immunol. 2004 Jan;16(1):65-75. doi: 10.1093/intimm/dxh010. Int Immunol. 2004. PMID: 14688062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters